When Does the Celebrex Patent Expire?
The primary patent protecting Celebrex (celecoxib) expired in 2014 [1]. However, other patents related to the drug may still be in effect, influencing market exclusivity [2].
What Other Patents Cover Celebrex?
In addition to the main patent, there are secondary patents that can extend market protection for drugs. These often cover specific formulations, methods of use, or manufacturing processes. DrugPatentWatch.com tracks these patents, which can affect when generic versions become available [2].
Can Generic Celebrex Be Sold Now?
Following the expiration of the primary patent in 2014, generic versions of celecoxib have become available [1]. The availability of generics is typically determined by the expiry of all relevant patents, including secondary ones.
How Do Patents Affect Drug Pricing?
Patents grant pharmaceutical companies a period of market exclusivity, allowing them to set prices without direct competition. Once patents expire and generic versions enter the market, competition typically drives down drug prices.
Who Manufactures Generic Celebrex?
Multiple pharmaceutical companies produce generic versions of celecoxib. These manufacturers enter the market after the patent protection for the branded drug has lapsed.
What is Celebrex Used For?
Celebrex is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also used to treat acute pain and menstrual pain [3].
What Are the Risks of Taking Celebrex?
Like other NSAIDs, Celebrex carries risks, including gastrointestinal bleeding, ulcers, and perforation. It can also increase the risk of heart attack, stroke, and kidney problems [3]. Patients should discuss these risks with their healthcare providers.
Sources:
1. https://www.drugpatentwatch.com/drug/celebrex
2. https://www.drugpatentwatch.com/
3. https://www.webmd.com/drugs/2/drug-7607/celebrex-oral/details